← FDA Drug Approvals (Drugs@FDA)

CEFAZOLIN SODIUM

NDA · New Drug Application · Sponsor: HQ SPCLT PHARMA · Approved 2023-05-08

Drug application

FDA Application #

NDA211413

Application type

New Drug Application

Brand name

CEFAZOLIN SODIUM

Generic name

CEFAZOLIN

Active ingredients

CEFAZOLIN SODIUM

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

HQ SPCLT PHARMA

Manufacturer

WG Critical Care, LLC

First approval

2023-05-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown